PAD4 inhibition has yielded promising anti-inflammatory results in various conditions like asthma, spinal cord injury, and inflammatory bowel disease (IBD) (Feng et al., 2021; Chen et al., 2023c; Wang et al., 2024). This evidence concerns the gene PADI4 and inflammatory bowel disease.